Le service d'ophtalmologie est situé au secteur bleu, porte 12, rez-de-chaussée.

Nous vous accueillons du lundi au jeudi de 8h30 à 17h et le vendredi de 8h30 à 16h pour tout renseignement.

2 rue Ambroise Paré
75010 Paris

Tél. 0149956478 / 0149956479
Fax 0149956483

Rétinopathie & maculopathie diabétique

1. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
2. Three Different Optical Coherence Tomography Angiography Measurement Methods for Assessing Capillary Density Changes in Diabetic Retinopathy.
3. Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).
4. Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy.
5. Correlation Between Cystoid Spaces In Chronic Diabetic Macular Edema And Capillary Nonperfusion Detected By Optical Coherence Tomography Angiography.
6. Improved Automated Detection of Diabetic Retinopathy on a Publicly Available Dataset Through Integration of Deep Learning.
7. Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study.
8. Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials.
9. Symmetry in early response to intravitreal ranibizumab in bilateral diabetic macular oedema.
10. Relevance of Retinal Thickness Changes in the OCT Inner and Outer Rings to Predict Progression to Clinical Macular Edema: An Attempt of Composite Grading of Macular Edema.
11. Diabetic macular edema: Diagnosis and pre-treatment work-up
12. [Physician information sheet: Treatment of diabetic macular edema].
13. Capillary Plexus Anomalies In Diabetic Retinopathy On Optical Coherence Tomography Angiography.
14. Intravitreal Corticosteroids In Diabetic Macular Edema: Pharmacokinetic Considerations.
15. Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study.
16. Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2.
17. One-year progression of diabetic subclinical macular edema in eyes with mild nonproliferative diabetic retinopathy: location of the increase in retinal thickness.
18. Retinal layer location of increased retinal thickness in eyes with subclinical and clinical macular edema in diabetes type 2.
19. Efficacy of dexamethasone intravitreal implant for the treatment of diabetic macular edema.
20. Correlation between ganglion cell layer thinning and poor visual function after resolution of diabetic macular edema.
21. Vitrectomy With Internal Limiting Membrane Peeling For Tractional And Nontractional Diabetic Macular Edema: Long-term Results of a Comparative Study.
22. Effects of fenofibric acid on diabetic macular edema: the MacuFen study.
23. Surgical outcomes of florid diabetic retinopathy treated with antivascular endothelial growth factor.
24. Exudate detection in color retinal images for mass screening of diabetic retinopathy.
25. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
26. Influence of pulse pressure and spontaneous variations of macular thickness in patients with diabetic macular oedema.
27. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study.
28. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives.
    1. Ophthalmology
    2. Ophthalmic Surg Laser Imaging Retina
    3. Ophthalmologica
    4. Eye (Lond)
    5. Retina
    6. Invest Ophthalmol Vis Sci
    7. Clin Ophthalmol
    8. Clin Ophthalmol
    9. Acta Ophthalmol
    10. Ophthalmic Res
    11. J Fr Ophtalmol
    12. J Fr Ophtalmol
    13. Retina
    14. Retina
    15. Curr Med Res Opin
    16. Invest Ophthalmol Vis Sci
    17. Ophthalmic Res
    18. Ophthalmic Res
    19. Eur J Ophthalmol
    20. Invest Ophthalmol Vis Sci
    21. Retina
    22. Ophthalmic Epidemiol
    23. Retina
    24. Med Image Anal
    25. Ophthalmology
    26. Acta Ophthalmol
    27. Ophthalmology
    28. Trends Endocrinol Metab

Chirurgie : Trou maculaire

1. Measurement of full-thickness macular hole size using en face optical coherence tomography.
2. Size and vitreomacular attachment of primary full-thickness macular holes.
3. Classification of vitreomacular adhesion and macular holes.
4. Vitrectomy with internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole.
    1. Eye (Lond)
    2. Br J Ophthalmol
    3. J Fr Ophtalmol
    4. Ophthalmology

Chirurgie : MER

1. Epiretinal Membrane in Dome-Shaped Macula Complicated with Serous Retinal Detachment: Transient Efficacy of Surgery.
2. Occurrence rate of retinal detachment after small gauge vitrectomy for idiopathic epiretinal membrane.
3. Evolution of Subfoveal Detachments Secondary to Idiopathic Epiretinal Membranes after Surgery.
4. Epiretinal membranes.
5. Long-Term Outcome Of Epiretinal Membrane Surgery In Young Children.
    1. Case Rep Ophthalmol
    2. Eye (Lond)
    3. Ophthalmology
    4. J Fr Ophtalmol
    5. Retina

Chirurgie : Complications chirurgicales

1. Acute Pseudophakic Cystoid Macular Edema Imaged By Optical Coherence Tomography Angiography.
2. Posterior Vitreous Detachment In Highly Myopic Eyes Undergoing Vitrectomy.
3. Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study.
    1. Retina
    2. Retina
    3. Br J Ophthalmol


1. Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3.
2. A "fast track" to improve management of neovascular age related macular degeneration.
3. Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings.
4. Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study.
5. Identifying Predictors of Anti-VEGF Treatment Response in Patients with Neovascular Age-Related Macular Degeneration through Discriminant and Principal Component Analysis.
6. Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study.
7. Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study.
8. Long-Term Evolution Of Dome-Shaped Macula: Increased Macular Bulge is Associated With Extended Macular Atrophy.
9. Overview of medical practices in wet AMD in France.
10. Peripapillary Retinal Pigment Epithelium Changes In Age-Related Macular Degeneration.
11. Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial.
12. Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting.
13. Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration.
14. Review and expert opinion in age related macular degeneration. Focus on the pathophysiology, angiogenesis and pharmacological and clinical data.
15. Ultrasound assessment of ocular vascular effects of repeated intravitreal injections of ranibizumab for wet age-related macular degeneration.
16. Risk factors for exudative age-related macular degeneration in a large French case-control study.
17. Bimonthly ranibizumab for neovascular age-related macular degeneration.
    1. Ophthalmology
    2. J Fr Ophtalmol
    3. Ophthalmology
    4. Eye (Lond)
    5. Ophthalmic Res
    6. Eye (Lond)
    7. Br J Ophthalmol
    8. Retina
    9. J Fr Ophtalmol
    10. Retina
    11. Ophthalmologica
    12. J Fr Ophtalmol
    13. Br J Ophthalmol
    14. J Fr Ophtalmol
    15. Acta Ophthalmol
    16. Graefes Arch Clin Exp Ophthalmol
    17. Ophthalmologica

Myopie forte

1. Preoperative Factors Influencing Visual Recovery After Vitrectomy For Myopic Foveoschisis.
2. Benefit Of Intraoperative Optical Coherence Tomography For Vitreomacular Surgery In Highly Myopic Eyes.
3. Macular Choroidal Thickness In Myopic Eyes With And Without A Dome-Shaped Macula: A Case-Control Study.
4. Understanding The Determinants Of Myopic Choroidal Neovascularization And Response To Treatment.
5. Posterior Vitreous Detachment In Highly Myopic Eyes Undergoing Vitrectomy.
6. Long-Term Variable Outcome Of Myopic Choroidal Neovascularization Treated With Ranibizumab.
7. Intravitreal Ranibizumab And/Or Dexamethasone Implant For Macular Edema Secondary To Retinal Vein Occlusion.
8. Treatment Of Myopic Choroidal Neovascularization: Recommendations Of The Fédération France Macula.
9. Choroidal Neovascularization Induces Retinal Edema And Its Treatment Addresses This Problem.
    1. Retina
    2. Retina
    3. Ophthalmologica
    4. Eur J Ophthalmol
    5. Retina
    6. Jpn J Ophthalmol
    7. Ophthalmologica
    8. J Fr Ophtalmol
    9. J Ophthalmic Vis Res


1. Visibility Of Blood Flow On Optical Coherence Tomography Angiography In A Case Of Branch Retinal Artery Occlusion.
2. Sustained Benefits Of Ranibizumab With Or Without Laser In Branch Retinal Vein Occlusion: 24-Month Results Of The BRIGHTER Study.
3. Individualized Stabilization Criteria-Driven Ranibizumab Versus Laser In Branch Retinal Vein Occlusion: Six-Month Results Of BRIGHTER.
4. Individualized Ranibizumab Regimen Driven By Stabilization Criteria For Central Retinal Vein Occlusion: Twelve-Month Results Of The CRYSTAL Study.
5. [Management Of Macular Edema Secondary To Retinal Vein Occlusion].
6. Ranibizumab In Retinal Vein Occlusion: Treatment Recommendations By An Expert Panel.
7. Dexamethasone Intravitreal Implants For Retinal Vein Occlusion In A Clinical Setting.
    1. J Ophthalmic Vis Res
    2. Ophthalmology
    3. Ophthalmology
    4. Ophthalmology
    5. J Fr Ophtalmol
    6. Br J Ophthalmol
    7. Acta Ophthalmol


1. Optical Coherence Tomography Angiography Shows Deep Capillary Plexus Hypoperfusion In Incomplete Central Retinal Artery Occlusion.     1. Retin Cases Brief Rep


1. Outer Retina Capillary Invasion And Ellipsoid Zone Loss In Macular Telangiectasia Type 2 Imaged By Optical Coherence Tomography Angiography.
2. Cone Density Loss On Adaptive Optics In Early Macular Telangiectasia Type 2.
3. Management of idiopathic retinal vasoproliferative tumors by slit-lamp laser or endolaser photocoagulation.
4. Microvascular retinal abnormalities in acute intracerebral haemorrhage and lacunar infarction.
    1. Retina
    2. Retina
    3. Am J Ophthalmol
    4. Rev Neurol (Paris)

Neuropathie optique

1. Mutations in TUBB4B Cause a Distinctive Sensorineural Disease.     1. Am J Hum Genet

Rétinopathies toxiques

1. Update on recommendations for screening for hydroxychloroquine retinopathy.     1. J Fr Ophtalmol


1. Optical Coherence Tomography Angiography Of Flat Irregular Pigment Epithelium Detachment In Chronic Central Serous Chorioretinopathy.
2. Central Serous Chorioretinopathy: Recent Findings And New Physiopathology Hypothesis.
3. Spironolactone For Nonresolving Central Serous Chorioretinopathy: A Randomized Controlled Crossover Study.
4. Flat Irregular Retinal Pigment Epithelium Detachments In Chronic Central Serous Chorioretinopathy And Choroidal Neovascularization.
5. Reply: To Pmid 23719402.
6. Pachychoroid: An Inherited Condition?
    1. Retina
    2. Prog Retin Eye Res
    3. Retina
    4. Am J Ophthalmol
    5. Retina
    6. Retina


1. Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T Cells.
2. Late posterior segment relapses in a series of Vogt-Koyanagi-Harada disease.
3. Anti-vascular endothelial growth factor acts on retinal microglia/macrophage activation in a rat model of ocular inflammation.
    1. J Immunol
    2. Acta Ophthalmol
    3. Mol Vis


1. Mapping The Retinas Of A Patient Using A Mixed Set Of Fundus Photographs From Both Eyes.
2. Comparing Parafoveal Cone Photoreceptor Mosaic Metrics In Younger And Older Age Groups Using An Adaptive Optics Retinal Camera.
3. Indocyanine-Green-Guided Targeted Laser Photocoagulation Of Capillary Macroaneurysms In Macular Oedema: A Pilot Study.
4. New Insight Into The Macular Deep Vascular Plexus Imaged By Optical Coherence Tomography Angiography.
5. Meaning Of Visualizing Retinal Cone Mosaic On Adaptive Optics Images.
6. Imaging In Retina Units: Changes Observed During The Last 12 Years.
    1. Conf Proc IEEE Eng Med Biol Soc
    2. Ophthalmic Surg Lasers Imaging Retina
    3. Br J Ophthalmol
    4. Retina
    5. Am J Ophthalmol
    6. Eur J Ophthalmol


1. Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice.
2. Treat-And-Extend Regimens With Anti-Vegf Agents In Retinal Diseases: A Literature Review And Consensus Recommendations.
    1. BMC Ophthalmol
    2. Retina


1. Protection of Glial Müller Cells by Dexamethasone in a Mouse Model of Surgically Induced Blood-Retinal Barrier Breakdown.
2. Ocular manifestations of autoimmune polyendocrinopathy syndrome type 1.
3. Keratopathy in Autoimmune Polyendocrinopathy Syndrome Type 1.
4. Subretinal mononuclear phagocytes induce cone segment loss via IL-1β.
5. AAV-mediated gene therapy in Dystrophin-Dp71 deficient mouse leads to blood-retinal barrier restoration and oedema reabsorption.
6. Automatic detection of referral patients due to retinal pathologies through data mining.
7. Predictive Value of Outer Retina En Face OCT Imaging for Geographic Atrophy Progression.
8. Altered astrocyte morphology and vascular development in dystrophin-Dp71-null mice.
9. Choroidal mast cells in retinal pathology: a potential target for intervention.
10. Dystrophin Dp71 gene deletion induces retinal vascular inflammation and capillary degeneration.
11. IgG4-related Disease Masquerading as Recurrent Scleritis and Chronic Conjunctivitis.
12. Lack of dystrophin protein Dp71 results in progressive cataract formation due to loss of fiber cell organization.
13. Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.
14. A mysterious post-traumatic pulsatile exophthalmos.
    1. Invest Ophthalmol Vis Sci
    2. Curr Opin Ophthalmol
    3. Cornea
    4. Elife
    5. Hum Mol Genet
    6. Med Image Anal
    7. Invest Ophthalmol Vis Sci
    8. Glia
    9. Am J Pathol
    10. Hum Mol Genet
    11. Ocul Immunol Inflamm
    12. Mol Vis
    13. Am J Hum Genet
    14. Intensive Care Med